# Aspirin in Reduction of Tension II Study

Study · id `cardio:ct-nct01379079` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01379079](<https://clinicaltrials.gov/study/NCT01379079>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01379079

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.

## Technical summary

Registry record NCT01379079. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 290 participants (enrolled count; ClinicalTrials.gov record NCT01379079, source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)
- Start date: 2011-04 (registry gives no type) (ClinicalTrials.gov record NCT01379079, source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)
- Primary completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01379079, source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)
- Completion: 2013-10 (actual) (ClinicalTrials.gov record NCT01379079, source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT01379079, source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01379079-2014-05-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aspirin in Reduction of Tension II Study
- Acronym: ASPIRETENSION
- Condition: Hypertension
- Condition: Cardiovascular Diseases
- Intervention (Drug): Acetylsalicylic acid
- Intervention (Drug): Acetylsalicylic acid lysinate
- Lead sponsor: Leiden University Medical Center
- Lead sponsor class: OTHER
- Collaborator: Netherlands Heart Foundation
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: Leiden University Medical Center (`cardio:org-leiden-university-medical-center`)
- Registry lists this organization as a collaborator: Netherlands Heart Foundation (`cardio:org-netherlands-heart-foundation`)

## Provenance

Content hash: f273a7fafa177ecc204a3cd2d5e8fdb28925306985c0f0ccc4a5eea565feda0e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
